Background: Genomic epidemiology of antibiotic resistance is not sufficiently studied in low-income countries. Objectives: To determine prevalence of ESBL production, and resistome and virulome profiles, of Klebsiella pneumoniae isolated at Jimma Medical Center, Ethiopia. Methods: Strains isolated from patients with suspected infections between June and November 2016 were characterized by MALDI-TOF for species identification and disc diffusion for antimicrobial susceptibility testing. All K. pneumoniae isolates were characterized by double disc diffusion for ESBL production and all ESBL-producing strains (ESBL-KP) were subjected to WGS on the Illumina (HiSeq 2500) platform. DNA was extracted by automated systems (MagNA Pure 96). Genome asse...
PKBackground: The increasing rates of antimicrobial resistance observed in the nosocomial pathogen K...
Background: The prevalence of extended-spectrum -lactamases (ESBLs) have been reported in clinical i...
ABSTRACT BACKROUND: The increasing rates of antimicrobial resistance observed in the nosocomial path...
Objectives: The burden of antimicrobial resistance and spread of epidemic clones are rarely reported...
Objectives: Infections caused by multidrug-resistant Enterobacterales pose a significant challenge t...
OBJECTIVES: Infections caused by multidrug-resistant Enterobacterales pose a significant challenge t...
Objectives: ESBL-producing Klebsiella pneumoniae (KPN) pose a major threat to human health globally....
Background: The prevalence of extended-spectrum -lactamases (ESBLs) have been reported in clinical i...
Background: The prevalence of extended-spectrum -lactamases (ESBLs) have been reported in clinical i...
Background: The prevalence of extended-spectrum -lactamases (ESBLs) have been reported in clinical i...
OBJECTIVES: ESBL-producing Klebsiella pneumoniae (KPN) pose a major threat to human health globally....
Background: The prevalence of extended-spectrum -lactamases (ESBLs) have been reported in clinical i...
Multidrug resistant (MDR) Klebsiella pneumoniae is a common cause of nosocomial infections worldwide...
OBJECTIVES: To use the nationwide Norwegian surveillance programme on resistant microbes in humans (...
OBJECTIVES ESBL-producing Klebsiella pneumoniae (KPN) pose a major threat to human health globally....
PKBackground: The increasing rates of antimicrobial resistance observed in the nosocomial pathogen K...
Background: The prevalence of extended-spectrum -lactamases (ESBLs) have been reported in clinical i...
ABSTRACT BACKROUND: The increasing rates of antimicrobial resistance observed in the nosocomial path...
Objectives: The burden of antimicrobial resistance and spread of epidemic clones are rarely reported...
Objectives: Infections caused by multidrug-resistant Enterobacterales pose a significant challenge t...
OBJECTIVES: Infections caused by multidrug-resistant Enterobacterales pose a significant challenge t...
Objectives: ESBL-producing Klebsiella pneumoniae (KPN) pose a major threat to human health globally....
Background: The prevalence of extended-spectrum -lactamases (ESBLs) have been reported in clinical i...
Background: The prevalence of extended-spectrum -lactamases (ESBLs) have been reported in clinical i...
Background: The prevalence of extended-spectrum -lactamases (ESBLs) have been reported in clinical i...
OBJECTIVES: ESBL-producing Klebsiella pneumoniae (KPN) pose a major threat to human health globally....
Background: The prevalence of extended-spectrum -lactamases (ESBLs) have been reported in clinical i...
Multidrug resistant (MDR) Klebsiella pneumoniae is a common cause of nosocomial infections worldwide...
OBJECTIVES: To use the nationwide Norwegian surveillance programme on resistant microbes in humans (...
OBJECTIVES ESBL-producing Klebsiella pneumoniae (KPN) pose a major threat to human health globally....
PKBackground: The increasing rates of antimicrobial resistance observed in the nosocomial pathogen K...
Background: The prevalence of extended-spectrum -lactamases (ESBLs) have been reported in clinical i...
ABSTRACT BACKROUND: The increasing rates of antimicrobial resistance observed in the nosocomial path...